DNA methylation profiles of differentiated‐type gastric carcinomas with distinct mucin phenotypes

Gastric carcinomas (GC) are classified into four phenotypes according to mucin expression. Previous studies revealed the association of distinct genetic profiles in GC with mucin phenotypic expression; however, the roles of epigenetic changes, such as DNA methylation, are poorly understood. We examined whether the phenotypic expression of GC was associated with DNA methylation of hMLH1, MGMT, p16INK4a, RAR‐beta or CDH1. Expression of HGM, M‐GGMC‐1, MUC2, and CD10 was analyzed immunohistochemically in 33 advanced GC with differentiated histology. HGM was expressed in 14 (42.4%) cases, M‐GGMC‐1 in five (15.2%) cases, MUC2 in 15 (45.5%) cases and CD10 in 18 (54.5%) cases. DNA methylation was detected in five (15.2%) cases for hMLH1, 11 (33.3%) cases for MGMT, 13 (39.4%) cases for p16INK4a, 17 (51.5%) cases for RAR‐beta and 14 (42.4%) cases for CDH1 by bisulfite‐polymerase chain reaction and methylation‐specific polymerase chain reaction. DNA methylation of hMLH1 occurred more frequently in MUC2‐negative GC than in MUC2‐positive GC (P = 0.0488, Fisher's exact test). In contrast, MGMT was more frequently methylated in MUC2‐positive GC than in MUC2‐negative GC (P = 0.0078, Fisher's exact test). There was no correlation between gastric or intestinal‐markers and methylation of the p16INK4a, RAR‐beta and CDH1 genes. These results indicate that DNA methylation of specific genes, such as hMLH1 and MGMT, may be involved partly in the distinct phenotypic expression of GC. (Cancer Sci 2005; 96: 474 –479)

[1]  Kazuhiro Yoshida,et al.  DNA methylation of multiple genes in gastric carcinoma: Association with histological type and CpG island methylator phenotype , 2003, Cancer science.

[2]  Hwoong-Yong Jung,et al.  Profile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric Carcinogenesis , 2003, Laboratory Investigation.

[3]  T. Tsukamoto,et al.  Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia , 2003, Cancer science.

[4]  R. Seruca,et al.  Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. , 2003, Cancer letters.

[5]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[6]  H. Yokozaki,et al.  Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas , 2002, The Journal of pathology.

[7]  S. Nishizuka,et al.  Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. , 2002, The American journal of pathology.

[8]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[9]  H. Lee,et al.  Distinct Clinical Features and Outcomes of Gastric Cancers with Microsatellite Instability , 2002, Modern Pathology.

[10]  H. Yokozaki,et al.  Promoter Methylation Status of the DNA Repair Genes hMLH1 and MGMT in Gastric Carcinoma and Metaplastic Mucosa , 2002, Pathobiology.

[11]  K. Hirokawa,et al.  Age‐related hypermethylation of the hMLH1 promoter in gastric cancers , 2001, International journal of cancer.

[12]  H. Yokozaki,et al.  Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma , 2001, International journal of cancer.

[13]  T. Tsuji,et al.  The E‐cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas , 2001, International journal of cancer.

[14]  R. Lotan,et al.  Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. , 2001, Differentiation; research in biological diversity.

[15]  J. Herman,et al.  Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. , 2001, Cancer research.

[16]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[17]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[18]  H. Watanabe,et al.  Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. , 2000, The American journal of pathology.

[19]  H. Watanabe,et al.  Cellular phenotypes of differentiated‐type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways , 2000, The Journal of pathology.

[20]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[21]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.

[22]  G. Kang,et al.  Correlation of p16 Hypermethylation with p16 Protein Loss in Sporadic Gastric Carcinomas , 2000, Laboratory Investigation.

[23]  J. Fujimoto,et al.  Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. , 2000, Journal of gastroenterology.

[24]  H. Yokozaki,et al.  Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype , 1999, International journal of cancer.

[25]  J. Herman,et al.  Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. , 1999, Cancer research.

[26]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[27]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[28]  A. Wolffe,et al.  How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.

[29]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Stolte,et al.  Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis , 1996, Virchows Archiv.

[31]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[32]  S. Hirohashi,et al.  p53 Mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer , 1993, International journal of cancer.

[33]  A. Razin,et al.  DNA methylation and gene expression , 1991, Microbiological reviews.

[34]  M. Tatematsu,et al.  Gastric and Intestinal Phenotypic Expression of Human Stomach Cancers as Revealed by Pepsinogen lmmunohistochemistry and Mucin Histochemistry , 1990, Acta pathologica japonica.

[35]  L. Villani,et al.  Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours. , 1987, Pathology, research and practice.

[36]  H. Sugano,et al.  Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. , 1968, Gan.

[37]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[38]  J. Watari,et al.  Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. , 2003, Human pathology.

[39]  S. Leung,et al.  hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. , 1999, Cancer research.

[40]  F. Borchard,et al.  Intramucosal carcinomas of the stomach: phenotypic expression and loss of heterozygosity at microsatellites linked to the APC gene. , 1998, Pathology, research and practice.

[41]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.